Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Researchers have modified an oncolytic virus so that it blocks the protein TGF-beta, helping expose tumors to the immune system.

IJMS, Free Full-Text

Genes, Free Full-Text

Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT) - eBioMedicine

Oncolytic viruses: a new class of immunotherapy drugs

Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme - ScienceDirect

Frontiers Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma

Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages, Cancer Cell International

Oncolytic virotherapy

Virus-Protein Corona Replacement Strategy to Improve the Antitumor Efficacy of Intravenously Injected Oncolytic Adenovirus

Cancers, Free Full-Text

Cancers, Free Full-Text